Brian Lloyd
First SEC filing: May 28, 2013 · Latest: May 28, 2013
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| March 12, 2014 | MED | F | 657 | $26.48 | $17,397 | 1,865 Direct | -26.05% | Disposed | -55.7% (price as of 2026-10-02) |
| Feb. 5, 2014 | MED | A | 2,000 | · | · | 4,000 Direct | +100.00% | Acquired | (price as of 2026-10-02) |
| Feb. 5, 2014 | MED | A | 1,875 | · | · | 2,522 Direct | +289.80% | Acquired | (price as of 2026-10-02) |
| May 23, 2013 | MED | A | 647 | $28.32 | $18,323 | 647 Direct | · | Acquired | -58.6% (price as of 2026-10-02) |
| Feb. 19, 2013 | MED | A | 2,000 | · | · | 2,000 Direct | · | Acquired | (price as of 2026-10-02) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 5, 2014 | MED | Stock Options | Common Stock | $26.52 | Feb. 5, 2024 | 2,000 | Acquired |
| Feb. 19, 2013 | MED | Stock Options | Common Stock | $24.26 | Feb. 19, 2023 | 2,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| May 28, 2013 | MED | Common Shares | 647 | Direct |